Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q1 2025 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2025-04-11

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: Apr 11, 2025

Total Value: $438M (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 65.6%

Value $287M Shares 19,963,157 Share Price $14.38 Est. Cost/Share $20.88 Unrealized @ Report Date —

NAMS NEWAMSTERDAM PHARMA COMPANY 13.4%

Value $58.74M Shares 2,869,565 Share Price $20.47 Est. Cost/Share $10.96 Unrealized @ Report Date +86.8%

PHAT PHATHOM PHARMACEUTICALS INC 10.7%

Value $46.8M Shares 7,464,572 Share Price $6.27 Est. Cost/Share $13.72 Unrealized @ Report Date -54.3%

— RAPT THERAPEUTICS INC 6.2%

Value $27.27M Shares 22,352,000 Share Price $1.22 Est. Cost/Share $1.58 Unrealized @ Report Date —

AURA AURA BIOSCIENCES INC 4.1%

Value $17.81M Shares 3,039,892 Share Price $5.86 Est. Cost/Share $17.87 Unrealized @ Report Date -67.2%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$287M	65.6%	$14.38	$20.88	—	SPONSORED ADS	152309100
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$58.74M	13.4%	$20.47	$10.96	+86.8%	ORDINARY SHARES	N62509109
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$46.8M	10.7%	$6.27	$13.72	-54.3%	COM	71722W107
—	RAPT THERAPEUTICS INC	22,352,000	$27.27M	6.2%	$1.22	$1.58	—	COM	75382E109
AURA	AURA BIOSCIENCES INC	3,039,892	$17.81M	4.1%	$5.86	$17.87	-67.2%	COM	05153U107